Specific focus on clinical cardiovascular pharmacology
Pharmacology is an extremely important part of cardiology today. Nearly every patient with cardiac disease is on some kind of medication. Already there are almost half a million references to ‘cardiovascular pharmacology’ in MEDLINE and the number of papers within this area is growing very fast. More studies are needed to improve outcomes of patients with cardiovascular disease, which is the most common cause of death globally.
The official journal of the ESC Working Group on Cardiovascular Pharmacotherapy and a brand new addition to the ESC Journal Family, EHJ - Cardiovascular Pharmacotherapy aims to publish reports specifically describing clinical research relevant to cardiovascular drug therapy.
Submit your paper
Visit the journal's home page
ISSN 2055-6837Volume 3 - year 20174 issues
Members of the Working Group on Cardiovascular PharmacotherapyOnline: access included in the MembershipCombined (print & online): 103.80 EUR
ESC Constituent Bodies MembersCombined (print & online): 103.80 EUR
ESC Professional/ Professional Plus MembersCombined (print & online): 77.85 EUR
Professor Stefan Agewall, (NO), MD PhD, FESC, FACC, is a senior consultant and professor of cardiology at Oslo University Hospital. More than 170 peer-reviewed publications in the cardiovascular field. Chairman of the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology 2014-2016. Senior Consulting Editor of the European Heart Journal. Board member of the European Society of Cardiology Committee for Practice Guidelines and Editorial board member of the European Heart Journal.
Our mission: To reduce the burden of cardiovascular disease
© 2017 European Society of Cardiology. All rights reserved